Nevro Corp Stock News
$9.79
-0.720 (-6.85%)
At Close: May 10, 2024
Ecolab (ECL) to Report Q3 Earnings: What's in the Offing?
01:44pm, Tuesday, 25'th Oct 2022 Zacks Investment Research
Ecolab's (ECL) third-quarter results are likely to reflect continued strength in its Global Industrial segment.
DaVita (DVA) to Report Q3 Earnings: What's in the Offing?
04:08pm, Friday, 21'st Oct 2022 Zacks Investment Research
High labor costs, along with inflationary pressures, are likely to have weighed on DaVita's (DVA) third quarter's top line.
Nevro (NVRO) Gains Following FDA Approval for Senza HFX iQ
04:29pm, Friday, 14'th Oct 2022 Zacks Investment Research
Nevro (NVRO) gets FDA approval for its next-generation SCS system, Senza HFX iQ, for treating chronic back and leg pain.
Nevro (NVRO) Gains Following FDA Approval for Senza HFX iQ
01:33pm, Friday, 14'th Oct 2022
Nevro (NVRO) gets FDA approval for its next-generation SCS system, Senza HFX iQ, for treating chronic back and leg pain.
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
02:02pm, Wednesday, 12'th Oct 2022 Benzinga
Upgrades
For CME Group Inc (NASDAQ:CME), Deutsche Bank upgraded the previous rating of Hold to Buy. In the second quarter, CME Group showed an EPS of $1.97, compared to $1.64 from the year-ago quarte
3 Reasons to Retain Nevro (NVRO) Stock in Your Portfolio
04:19pm, Tuesday, 11'th Oct 2022 Zacks Investment Research
Investors continue to be optimistic about Nevro (NVRO), owing to its strength in the global SCS market.
What 4 Analyst Ratings Have To Say About Nevro
04:04pm, Tuesday, 11'th Oct 2022 Benzinga
Analysts have provided the following ratings for Nevro (NYSE:NVRO) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
1
3
0
0
Last 30D
0
3 Reasons to Retain Nevro (NVRO) Stock in Your Portfolio
01:32pm, Tuesday, 11'th Oct 2022
Investors continue to be optimistic about Nevro (NVRO), owing to its strength in the global SCS market.
Why Is Nevro (NVRO) Down 1% Since Last Earnings Report?
03:31pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nevro's (NVRO) PDN Therapy Gets Positive Coverage Updates
01:18pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Latest favorable coverage decisions for Nevro's (NVRO) PDN Therapy are expected to serve a wider patient pool.
Why Is Nevro (NVRO) Down 1% Since Last Earnings Report?
12:48pm, Friday, 02'nd Sep 2022
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock?
Nevro's (NVRO) PDN Therapy Gets Positive Coverage Updates
10:32am, Friday, 02'nd Sep 2022
Latest favorable coverage decisions for Nevro's (NVRO) PDN Therapy are expected to serve a wider patient pool.
Here's Why You Should Hold on to Nevro (NVRO) Stock for Now
12:32pm, Tuesday, 30'th Aug 2022 Zacks Investment Research
Investors continue to be optimistic about Nevro (NVRO), owing to its strength in the global SCS market.
Here's Why You Should Hold on to Nevro (NVRO) Stock for Now
09:47am, Tuesday, 30'th Aug 2022
Investors continue to be optimistic about Nevro (NVRO), owing to its strength in the global SCS market.
Nevro Corp. (NVRO) CEO Keith Grossman on Q2 2022 Results - Earnings Call Transcript
11:27pm, Saturday, 06'th Aug 2022
Nevro Corp. (NYSE:NVRO ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Julie Dewey - Corporate Communications & IR Officer Keith Grossman - Chairman, President & CEO
